AU2001252463A1 - Thiophene derivatives useful as anticancer agents - Google Patents
Thiophene derivatives useful as anticancer agentsInfo
- Publication number
- AU2001252463A1 AU2001252463A1 AU2001252463A AU5246301A AU2001252463A1 AU 2001252463 A1 AU2001252463 A1 AU 2001252463A1 AU 2001252463 A AU2001252463 A AU 2001252463A AU 5246301 A AU5246301 A AU 5246301A AU 2001252463 A1 AU2001252463 A1 AU 2001252463A1
- Authority
- AU
- Australia
- Prior art keywords
- anticancer agents
- derivatives useful
- thiophene derivatives
- thiophene
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20968600P | 2000-06-06 | 2000-06-06 | |
US60209686 | 2000-06-06 | ||
PCT/IB2001/000766 WO2001094353A1 (en) | 2000-06-06 | 2001-05-02 | Thiophene derivatives useful as anticancer agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001252463A1 true AU2001252463A1 (en) | 2001-12-17 |
Family
ID=22779830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001252463A Abandoned AU2001252463A1 (en) | 2000-06-06 | 2001-05-02 | Thiophene derivatives useful as anticancer agents |
Country Status (22)
Country | Link |
---|---|
US (1) | US6964961B2 (en) |
EP (1) | EP1287001B1 (en) |
JP (1) | JP2003535867A (en) |
AR (1) | AR032621A1 (en) |
AT (1) | ATE277933T1 (en) |
AU (1) | AU2001252463A1 (en) |
BR (1) | BR0111377A (en) |
CA (1) | CA2411084A1 (en) |
DE (1) | DE60106022T2 (en) |
DO (1) | DOP2001000170A (en) |
EC (1) | ECSP014097A (en) |
ES (1) | ES2223827T3 (en) |
GT (1) | GT200100104A (en) |
MX (1) | MXPA02012034A (en) |
PA (1) | PA8518701A1 (en) |
PE (1) | PE20011373A1 (en) |
PT (1) | PT1287001E (en) |
SV (1) | SV2002000478A (en) |
TN (1) | TNSN01082A1 (en) |
TR (1) | TR200402656T4 (en) |
UY (1) | UY26750A1 (en) |
WO (1) | WO2001094353A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001279938B2 (en) * | 2000-08-09 | 2007-01-25 | Astrazeneca Ab | Indole, azaindole and indazole derivatives having VEGF inhibiting activity |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0012046A (en) * | 1999-07-01 | 2002-05-14 | Ajinomoto Kk | Heterocyclic compound, pharmaceutical composition, inhibitor of activation of ap-1 or an inhibitor of activation of nf-kappab, inhibitor of the production of inflammatory cytokine, and inhibitor of the production of matrix metalloprotease or inhibitor of the expression of inflammatory cell adhesion factor |
DE10164139A1 (en) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-heteroaryl carboxamides |
US7101898B2 (en) | 2002-02-01 | 2006-09-05 | Novo Nordisk A/S | Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
RU2366652C2 (en) * | 2002-02-01 | 2009-09-10 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Amides of aminoalkyl-substituted azetidines, pirrolidines, piperidines and azepanes |
JP2005527511A (en) | 2002-03-01 | 2005-09-15 | ファイザー インコーポレイテッド | Indolyl-urea derivatives of thienopyridine useful as anti-angiogenic agents and methods of use thereof |
EP1513516B1 (en) * | 2002-06-06 | 2008-12-03 | Boehringer Ingelheim Pharmaceuticals Inc. | SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
UA77303C2 (en) * | 2002-06-14 | 2006-11-15 | Pfizer | Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use |
US7488823B2 (en) * | 2003-11-10 | 2009-02-10 | Array Biopharma, Inc. | Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
CL2003002287A1 (en) * | 2002-11-25 | 2005-01-14 | Wyeth Corp | COMPOUNDS DERIVED FROM TIENO [3,2-b] -PIRIDINA-6-CARBONITRILOS AND TIENEO [2,3-b] -PIRIDINA-5-CARBONITRILS, PHARMACEUTICAL COMPOSITION, PROCEDURE OF PREPARATION AND INTERMEDIARY COMPOUNDS, AND THEIR USE IN THE TREATMENT OF CANCER, APOPLEJIA, OSTEOPOROSIS |
US7276519B2 (en) * | 2002-11-25 | 2007-10-02 | Wyeth | Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors |
CL2004000398A1 (en) | 2003-02-27 | 2005-03-18 | Uriach Y Compania S A J | COMPOUNDS DERIVED FROM PIRAZOLOPIRIDINAS, ITS SALTS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT DISEASES MEDIATED BY P38 KINASES, ESPECIALLY BY CITOCINES, TNF-ALFA, IL-1, IL-6 AND / OR IL-8, SUCH AS DISEASE |
EP1620094A4 (en) * | 2003-05-06 | 2010-04-28 | Glaxosmithkline Llc | Novel chemical compounds |
US7501427B2 (en) | 2003-08-14 | 2009-03-10 | Array Biopharma, Inc. | Quinazoline analogs as receptor tyrosine kinase inhibitors |
CN102432552B (en) | 2003-08-14 | 2016-01-20 | 阿雷生物药品公司 | As the quinazoline analogs of receptor tyrosine kinase inhibitors |
US7459562B2 (en) | 2004-04-23 | 2008-12-02 | Bristol-Myers Squibb Company | Monocyclic heterocycles as kinase inhibitors |
TW200538453A (en) | 2004-04-26 | 2005-12-01 | Bristol Myers Squibb Co | Bicyclic heterocycles as kinase inhibitors |
US7432373B2 (en) | 2004-06-28 | 2008-10-07 | Bristol-Meyers Squibb Company | Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
US7439246B2 (en) | 2004-06-28 | 2008-10-21 | Bristol-Myers Squibb Company | Fused heterocyclic kinase inhibitors |
US20050288290A1 (en) | 2004-06-28 | 2005-12-29 | Borzilleri Robert M | Fused heterocyclic kinase inhibitors |
US7772247B2 (en) | 2004-07-30 | 2010-08-10 | Methylgene Inc. | Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor |
MX2007014616A (en) | 2005-05-20 | 2009-08-12 | Methylgene Inc | Inhibitors of vegf receptor and hgf receptor signaling. |
MX2007014617A (en) | 2005-05-20 | 2008-02-11 | Methylgene Inc | Inhibitors of vegf receptor and hgf receptor signaling. |
WO2007035428A1 (en) | 2005-09-15 | 2007-03-29 | Bristol-Myers Squibb Company | Met kinase inhibitors |
AR056200A1 (en) * | 2005-09-27 | 2007-09-26 | Wyeth Corp | TIENO [2,3-B] PIRIDIN-5-CARBONITRILS AS INHIBITORS OF PROTEIN KINASE |
US7547782B2 (en) | 2005-09-30 | 2009-06-16 | Bristol-Myers Squibb Company | Met kinase inhibitors |
ES2364901T3 (en) * | 2005-11-15 | 2011-09-16 | Array Biopharma, Inc. | PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF DERIVATIVES OF N4-FENIL-QUINAZOLIN-4-AMINA. |
JP2009526761A (en) * | 2006-01-30 | 2009-07-23 | アレイ バイオファーマ、インコーポレイテッド | Heterobicyclic thiophene compounds and methods of use |
AU2008236670B2 (en) | 2007-04-05 | 2011-12-01 | Amgen Inc. | Aurora kinase modulators and method of use |
RU2498988C2 (en) | 2008-03-05 | 2013-11-20 | Метилджин, Инк. | Protein tyrosine kinase activity inhibitors |
US8404694B2 (en) | 2008-03-20 | 2013-03-26 | Amgen Inc. | Aurora kinase modulators and method of use |
WO2010019473A1 (en) | 2008-08-14 | 2010-02-18 | Amgen Inc. | Aurora kinase modulators and methods of use |
PL2540297T3 (en) | 2008-11-19 | 2015-12-31 | Forum Pharmaceuticals Inc | Treatment of Cognitive Disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof |
BRPI1014793A2 (en) * | 2009-05-11 | 2016-04-05 | Envivo Pharmaceuticals Inc | treatment of cognition disorders with certain alpha-7-nicotinic acid receptors in combination with acetyl cholinesterase inhibitors |
PL3029039T3 (en) | 2010-05-17 | 2018-04-30 | Forum Pharmaceuticals Inc. | Pharmaceutical formulations comprising crystalline forms of (r)-7-chloro-n-(quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide hydrochloride monohydrate |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
FR3080620B1 (en) * | 2018-04-27 | 2021-11-12 | Univ Paris Sud | COMPOUNDS WITH TUBULIN POLYMERIZATION INHIBITOR ACTIVITY AND IMMUNOMODULATORY PROPERTIES |
CN113648307B (en) * | 2021-09-23 | 2022-09-30 | 河南大学 | MII-tt-DTT and application thereof in preparing anti-colorectal cancer drugs |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3277623D1 (en) | 1981-07-31 | 1987-12-17 | Sloan Kettering Inst Cancer | Anti-leukemic beta-glycosyl c-nucleosides |
EP0364598A4 (en) | 1988-03-02 | 1992-01-15 | Yoshitomi Pharmaceutical Industries, Ltd. | 3,4-dihydrothieno 2,3-d¨pyrimidine compounds and pharmaceutical application thereof |
JPH02256667A (en) * | 1988-12-27 | 1990-10-17 | Masatoshi Yamato | Condensed quinoline-based compound and production thereof |
BR9101256A (en) | 1990-03-30 | 1991-11-05 | Dowelanco | COMPOUND, FUNGICIDE COMPOSITION, FUNGICIDE PROCESS, INSECTICIDE OR ACARICIDE COMPOSITION AND INSECTICIDE OR ACARICIDE PROCESS |
US5187168A (en) | 1991-10-24 | 1993-02-16 | American Home Products Corporation | Substituted quinazolines as angiotensin II antagonists |
US5583137A (en) | 1992-02-19 | 1996-12-10 | Pfizer Inc. | Heterocyclic compounds for enhancing antitumor activity |
US5654307A (en) | 1994-01-25 | 1997-08-05 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
IL112249A (en) | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
PT831829E (en) | 1995-06-07 | 2003-12-31 | Pfizer | PYRIMIDINE DERIVATIVES FROM HETEROCYCLICS OF FUSED RINGS |
AR004010A1 (en) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | HETERO CYCLIC COMPOUNDS |
ATE243697T1 (en) | 1995-12-08 | 2003-07-15 | Pfizer | SUBSTITUTED HETEROCYCLIC DERIVATIVES AS CRF ANTAGONISTS |
DE69708059T2 (en) | 1996-02-07 | 2002-07-18 | Janssen Pharmaceutica Nv | THIOPHENOPYRIMIDINE |
KR20000057228A (en) | 1996-11-27 | 2000-09-15 | 디. 제이. 우드, 스피겔 알렌 제이 | Fused bicyclic pyrimidine derivatives |
ZA986729B (en) * | 1997-07-29 | 1999-02-02 | Warner Lambert Co | Irreversible inhibitors of tyrosine kinases |
HUP0100287A3 (en) * | 1997-11-11 | 2003-04-28 | Pfizer Prod Inc | Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
-
2001
- 2001-05-02 AT AT01925786T patent/ATE277933T1/en not_active IP Right Cessation
- 2001-05-02 MX MXPA02012034A patent/MXPA02012034A/en active IP Right Grant
- 2001-05-02 PT PT01925786T patent/PT1287001E/en unknown
- 2001-05-02 ES ES01925786T patent/ES2223827T3/en not_active Expired - Lifetime
- 2001-05-02 JP JP2002501902A patent/JP2003535867A/en active Pending
- 2001-05-02 AU AU2001252463A patent/AU2001252463A1/en not_active Abandoned
- 2001-05-02 EP EP01925786A patent/EP1287001B1/en not_active Expired - Lifetime
- 2001-05-02 BR BR0111377-1A patent/BR0111377A/en not_active IP Right Cessation
- 2001-05-02 CA CA002411084A patent/CA2411084A1/en not_active Abandoned
- 2001-05-02 TR TR2004/02656T patent/TR200402656T4/en unknown
- 2001-05-02 DE DE60106022T patent/DE60106022T2/en not_active Expired - Fee Related
- 2001-05-02 WO PCT/IB2001/000766 patent/WO2001094353A1/en active IP Right Grant
- 2001-05-23 DO DO2001000170A patent/DOP2001000170A/en unknown
- 2001-06-01 PE PE2001000510A patent/PE20011373A1/en not_active Application Discontinuation
- 2001-06-04 AR ARP010102655A patent/AR032621A1/en unknown
- 2001-06-04 US US09/873,555 patent/US6964961B2/en not_active Expired - Fee Related
- 2001-06-05 SV SV2001000478A patent/SV2002000478A/en not_active Application Discontinuation
- 2001-06-05 GT GT200100104A patent/GT200100104A/en unknown
- 2001-06-05 UY UY26750A patent/UY26750A1/en not_active Application Discontinuation
- 2001-06-05 EC EC2001004097A patent/ECSP014097A/en unknown
- 2001-06-05 TN TNTNSN01082A patent/TNSN01082A1/en unknown
- 2001-06-06 PA PA20018518701A patent/PA8518701A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001279938B2 (en) * | 2000-08-09 | 2007-01-25 | Astrazeneca Ab | Indole, azaindole and indazole derivatives having VEGF inhibiting activity |
Also Published As
Publication number | Publication date |
---|---|
DE60106022D1 (en) | 2004-11-04 |
EP1287001B1 (en) | 2004-09-29 |
DOP2001000170A (en) | 2002-05-15 |
US20020042409A1 (en) | 2002-04-11 |
TR200402656T4 (en) | 2004-11-22 |
DE60106022T2 (en) | 2006-03-09 |
ES2223827T3 (en) | 2005-03-01 |
PE20011373A1 (en) | 2002-01-18 |
CA2411084A1 (en) | 2001-12-13 |
BR0111377A (en) | 2003-06-03 |
MXPA02012034A (en) | 2003-04-25 |
EP1287001A1 (en) | 2003-03-05 |
WO2001094353A1 (en) | 2001-12-13 |
ECSP014097A (en) | 2003-02-06 |
US6964961B2 (en) | 2005-11-15 |
UY26750A1 (en) | 2002-01-31 |
ATE277933T1 (en) | 2004-10-15 |
JP2003535867A (en) | 2003-12-02 |
TNSN01082A1 (en) | 2005-11-10 |
PA8518701A1 (en) | 2002-09-17 |
SV2002000478A (en) | 2002-07-03 |
GT200100104A (en) | 2002-01-31 |
PT1287001E (en) | 2004-12-31 |
AR032621A1 (en) | 2003-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001252463A1 (en) | Thiophene derivatives useful as anticancer agents | |
AU4137400A (en) | Heterocyclic derivatives useful as anticancer agents | |
AU2001280099A1 (en) | 4-acylaminopyrazole derivatives | |
AU2001230584A1 (en) | 1h-imidazopyridine derivatives | |
AU6714700A (en) | Cyclopropylindole derivatives | |
AU2882801A (en) | Azepine derivatives | |
AU2001230537A1 (en) | Pyridoxazine derivatives | |
AU2001281802A1 (en) | 6-phenylpyrrolopyrimidinedione derivatives | |
AU2001278790A1 (en) | 1h-imidazopyridine derivatives | |
AU7947000A (en) | Tricyclic fused-imidazole derivatives | |
AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
AU4890301A (en) | 6-methylnicotinamide derivatives as antiviral agents | |
AU2002212301A1 (en) | Diazacycloalkanedione derivatives | |
AU3670000A (en) | Novel thiazolobenzimidazole derivatives | |
AU5429000A (en) | Novel bicyclonucleoside derivatives | |
AU7952800A (en) | 2-alkoxybenzene derivatives | |
AU2002212959A1 (en) | Cycloalkylfluorosulfonamide derivatives | |
AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
AU2002215212A1 (en) | 1-methylcarbapenem derivatives | |
AU2001292122A1 (en) | Heterocyclic derivatives useful as pharmaceutical agents | |
AU2001234313A1 (en) | Novel phenylheteroalkylamine derivatives | |
AU2001254661A1 (en) | Aminosulfonylbiphenyl derivatives | |
AU2001230565A1 (en) | Perfluoroisopropylbenzene derivatives | |
AU2001275794A1 (en) | Pyrrole derivatives | |
AU2001242772A1 (en) | 3-substituted-4-pyrimidone derivatives |